Abeona Therapeutics Statistics
Share Statistics
Abeona Therapeutics has 48.8M
shares outstanding. The number of shares has increased by 18.48%
in one year.
| Shares Outstanding | 48.8M |
| Shares Change (YoY) | 18.48% |
| Shares Change (QoQ) | 11.65% |
| Owned by Institutions (%) | 0% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 3,367 |
| FTD / Avg. Volume | 0.26% |
Short Selling Information
The latest short interest is 5.45M, so 11.24% of the outstanding
shares have been sold short.
| Short Interest | 5.45M |
| Short % of Shares Out | 11.24% |
| Short % of Float | 11.78% |
| Short Ratio (days to cover) | 1.27 |
Valuation Ratios
The PE ratio is -3.59 and the forward
PE ratio is -52.6.
Abeona Therapeutics's PEG ratio is
0.09.
| PE Ratio | -3.59 |
| Forward PE | -52.6 |
| PS Ratio | 0 |
| Forward PS | 0.6 |
| PB Ratio | 5.19 |
| P/FCF Ratio | -3.91 |
| PEG Ratio | 0.09 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for Abeona Therapeutics.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.08,
with a Debt / Equity ratio of 0.52.
| Current Ratio | 6.08 |
| Quick Ratio | 6.08 |
| Debt / Equity | 0.52 |
| Debt / EBITDA | -0.36 |
| Debt / FCF | -0.39 |
| Interest Coverage | 15.26 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | $-468,632.35 |
| Employee Count | 136 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by 25.24% in the
last 52 weeks. The beta is 1.68, so Abeona Therapeutics's
price volatility has been higher than the market average.
| Beta | 1.68 |
| 52-Week Price Change | 25.24% |
| 50-Day Moving Average | 5.17 |
| 200-Day Moving Average | 5.6 |
| Relative Strength Index (RSI) | 47.62 |
| Average Volume (20 Days) | 1,306,624 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -64.21M |
| Net Income | -63.73M |
| EBITDA | -64.21M |
| EBIT | -67.94M |
| Earnings Per Share (EPS) | -1.55 |
Full Income StatementBalance Sheet
The company has 23.36M in cash and 23.05M in
debt, giving a net cash position of 309K.
| Cash & Cash Equivalents | 23.36M |
| Total Debt | 23.05M |
| Net Cash | 309K |
| Retained Earnings | -813.26M |
| Total Assets | 108.93M |
| Working Capital | 84.27M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -56.02M
and capital expenditures -2.45M, giving a free cash flow of -58.46M.
| Operating Cash Flow | -56.02M |
| Capital Expenditures | -2.45M |
| Free Cash Flow | -58.46M |
| FCF Per Share | -1.42 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
